Welcome to CSNpharm! For Research Use Only!
Amyloid-β
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN13757 | Tramiprosate | 3687-18-1 | Tramiprosate targets soluble A to decrease amyloid plaque deposition and maintains A in a non-fibrillar form. |
| CSN18386 | K 01-162 | 677746-25-7 | K 01-162 binds and destabilizes AO -amyloid with an EC50 of 80 nM |
| CSN23629 | HP-β-CD | 128446-35-5 | HP--CD is used to improve the solubility of lipophilic drugs It is also an inhibitor of amyloid- aggregation and A-induced toxicity |
| CSN19488 | Ginsenoside Re | 52286-59-6 | Ginsenoside Re is a panaxatriol saponin that has diverse in vitro and in vivo effects, including vasorelaxant, antioxidant, antihyperlipidemic, and angiogenic actions. |
| CSN11056 | Frentizole | 26130-02-9 | Frentizole, an immunosuppressive drug, is an inhibitor of the A-ABAD interaction. |
| CSN17194 | FPS-ZM1 | 945714-67-0 | FPS-ZM1 is a high-affinity RAGE-specific inhibitor that blocks Aβ binding to the V domain of RAGE with Ki of 25 ± 5 nM in RAGE-transfected CHO cells. |
| CSN11884 | EUK 134 | 81065-76-1 | EUK 134 a synthetic superoxide dismutase SODcatalase mimetic exhibits potent antioxidant activities and inhibits the formation of -amyloid and related amyloid fibril |
| CSN23259 | CRANAD 2 | 1193447-34-5 | CRANAD-2 is a difluoroboron-derivatized curcumins as near-infrared probe for in vivo detection of amyloid-beta deposits. Upon interacting with Abeta aggregates, CRANAD-2 undergoes a range of changes, which include a 70-fold fluorescence intensity increase, a 90 nm blue shift (from 805 to 715 nm), and a large increase in quantum yield. Moreover, this probe also shows a high affinity for Abeta aggregates (K(d) = 38.0 nM), a reasonable log P value (log P = 3), considerable stability in serum, and a weak interaction with albumin. After intravenous injection of this probe, 19-month-old Tg2576 mice exhibited significantly higher relative signal than that of the control mice over the same period of time. |
| CSN17400 | ARN2966 | 102212-26-0 | ARN2966 is a potent post-transcriptional modulator of APP expression and reduces expression of APP with resultant lower production of A |
| CSN19128 | Amyloid P-IN-1 | 1819986-22-5 | Amyloid P-IN-1 is a potential compound for treating amyloidosis Alzheimers disease type 2 diabetes mellitus and osteoarthritis |
| CSN21167 | Aftin-4 | 866893-90-5 | Aftin-4 is a potent and selective A42 inducer with an EC50 of 30 M |
| CSN22036 | 4-(6-Bromo-2-benzothiazolyl)benzenamine | 566169-97-9 | 4-(6-Bromo-2-benzothiazolyl)benzenamine is a β-amyloid PET (positron emission tomography) tracer that can be used in the diagnosis of neurological diseases, such as Alzheimer's and Down's syndrome. |
| CSN20235 | 2-D08 | 144707-18-6 | 2-D08 interacts with amyloid β, showing an anti-aggregatory and neuroprotective effect. |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
